Hjem › Interstitielle lungesygdomme › Kentucky
Interstitielle lungesygdomme kliniske forsøg i Kentucky
4 studier for Interstitielle lungesygdomme søger deltagere på steder i Kentucky.
Byer i Kentucky
Officiel studietekst (engelsk)
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Louisville
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 11. sep. 2026 · NCT07816185Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Kentucky, Lexington
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Norton Pulmonary Specialists, Louisville
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT06388421Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Kentucky, Lexington
- University of Louisville Healthcare Outpatient Research Clinic, Louisville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05943535Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.